Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 28Leukemia 24Leukemia, Myelomonocytic, Acute 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 14Leukemia, Monocytic, Acute 13Leukemia, Erythroblastic, Acute 11Congenital Abnormalities 11Leukemia, Megakaryoblastic, Acute 10Myelodysplastic Syndromes 7Myeloproliferative Disorders 6Burkitt Lymphoma 6Anemia, Refractory, with Excess of Blasts 6Leukemia, Myelomonocytic, Chronic 5Lymphoma 4Leukemia, Biphenotypic, Acute 4Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Promyelocytic, Acute 3Leukemia, Basophilic, Acute 3Myelodysplastic-Myeloproliferative Diseases 2Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2Leukemia, Eosinophilic, Acute 2Dendritic Cell Sarcoma, Interdigitating 2Sarcoma, Myeloid 1Neutropenia 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Lymphocytic, Chronic, B-Cell 1

Interventions

Cyclophosphamide 77Paclitaxel 48Trastuzumab 40Tamoxifen 39Doxorubicin 37Docetaxel 35Radiotherapy 32Fluorouracil 26Chemotherapy, Adjuvant 26Taxes 23Epirubicin 22Carboplatin 22Filgrastim 21Specimen Handling 19Methotrexate 19Magnetic Resonance Spectroscopy 19Neoadjuvant Therapy 18aldesleukin 16Peripheral Blood Stem Cell Transplantation 16Bevacizumab 13Lapatinib 12CMF regimen 12Anastrozole 12exemestane 11Goserelin 11Capecitabine 11Biopsy 11veliparib 10sargramostim 10fludarabine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Breast Neoplasms × Daunorubicin × Clear all
NCT00004207 2014-06-24

Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡